Left ventricular non-compaction in identical twins with thalassaemia and cardiac iron overload

Matthew Luckie1, Bruce Irwin, Satheesh Nair

  • 1Manchester Heart Centre, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL, UK. mluckie@doctors.net.uk

Insights

Transfusion-dependent beta-thalassaemia major can cause cardiac issues, including left ventricular dysfunction. A novel finding in affected twins was left ventricular non-compaction, previously unassociated with this condition.

Area of Science:

  • Cardiology
  • Hematology
  • Genetics

Background:

  • Transfusion-dependent beta-thalassaemia major is a genetic blood disorder requiring lifelong treatment.
  • Cardiac complications are a significant cause of morbidity and mortality in these patients.
  • Common cardiac issues include left ventricular hypertrophy and impaired systolic/diastolic function due to iron overload.

Observation:

  • A family cohort, including identical twins with beta-thalassaemia major, underwent cardiac assessment.
  • Cardiac magnetic resonance imaging revealed significant myocardial iron overload and reduced systolic function.
  • Echocardiography demonstrated severe left ventricular systolic and diastolic dysfunction.

Findings:

  • A previously unrecognized cardiac finding of left ventricular non-compaction was observed in affected individuals.
  • This finding was present in identical twins, suggesting a potential genetic or shared environmental influence.
  • The combination of iron overload, systolic/diastolic dysfunction, and non-compaction presents a unique cardiac profile.

Implications:

  • Left ventricular non-compaction may be an under-recognized cardiac manifestation in beta-thalassaemia major.
  • This finding necessitates a broader cardiac evaluation in patients with transfusion-dependent beta-thalassaemia major.
  • Further research is needed to elucidate the mechanisms linking beta-thalassaemia, iron overload, and left ventricular non-compaction.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...